Your browser doesn't support javascript.
loading
m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia.
Wu, Zijuan; Zuo, Xiaoling; Zhang, Wei; Li, Yongle; Gui, Renfu; Leng, Jiayan; Shen, Haorui; Pan, Bihui; Fan, Lei; Li, Jianyong; Jin, Hui.
Afiliación
  • Wu Z; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, 210029, China.
  • Zuo X; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Zhang W; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Li Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Gui R; Anqing First People's Hospital of Anhui Medical University, Anqing First People's Hospital of Anhui Province, Anqing, 246004, China.
  • Leng J; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, 210029, China.
  • Shen H; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Pan B; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 210029, China.
  • Fan L; Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, 210029, China.
  • Li J; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Jin H; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 210029, China.
Adv Sci (Weinh) ; 10(34): e2304895, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37821382
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Ribonucleoproteína Heterogénea-Nuclear Grupo C / Ácidos Grasos / ARN Circular Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Adv Sci (Weinh) Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Ribonucleoproteína Heterogénea-Nuclear Grupo C / Ácidos Grasos / ARN Circular Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Adv Sci (Weinh) Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania